HRTXのニュース
Heron Therapeutics PT Lowered to $5.50 at Cowen 2022/08/09 20:03:02 Investing.com
https://www.investing.com/news/pro/heron-therapeutics-pt-lowered-to-550-at-cowen-432SI-2868255
Heron Shares Jump After Equity Financing, Q2 Earnings 2022/08/09 18:10:16 Benzinga
Heron Therapeutics Inc (NASDAQ: HRTX ) reported Q2 sales of $27.63 million , +23.1% Y/Y, beating the consensus of $24.31 million. Oncology sales reached $25.1 million, up from $22.4 million a year ago. The company reported an EPS loss of $(0.55), narrower from $(0.62) a year ago but missing the consensus of $(0.50). In June … Full story available on Benzinga.com
Heron Therapeutics, Inc.''s (HRTX) CEO Barry Quart on Q2 2022 Results - Earnings Call Transcript 2022/08/09 18:05:05 Seeking Alpha
Heron Therapeutics, Inc. (NASDAQ:NASDAQ:HRTX) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants David Szekeres – Executive Vice President, Chief Operating…
Heron Therapeutics PT Lowered to $30 at Evercore ISI 2022/08/09 15:27:01 Investing.com
https://www.investing.com/news/pro/heron-therapeutics-pt-lowered-to-30-at-evercore-isi-432SI-2868115
Heron Therapeutics rises 16% on Q2 revenue beat, raises 2022 sales forecast (NASDAQ:HRTX) 2022/08/09 15:18:12 Seeking Alpha
Heron Therapeutics (HRTX) is trading 16% higher after it reported better-than-expected Q2 revenue, helped by higher sales of postoperative pain drug Zynrelef. The company also…
Investment - Heron Therapeutics, Inc. Expected to Post Quarterly Sales of $24.68 Million 2022/05/29 07:27:08 Business Mag
Equities research analysts expect that Heron Therapeutics, Inc. will report sales of $24.68 million for the current fiscal quarter, Zacks Investment Research reports. Two…
What Could Change After Heron Therapeutics Inc. (NASDAQ: HRTX) Gains 3.14% From The High-Point? 2022/05/27 12:00:00 Marketing Sentinel
Heron Therapeutics Inc. (NASDAQ:HRTX)’s traded shares stood at 3.33 million during the last session, with the company’s beta value hitting 1.42. At the close of trading, the stock’s price was $3.18, to imply an increase of 2.58% or $0.08 in intraday trading. The HRTX share’s 52-week high remains $16.63, putting it -422.96% down since that … What Could Change After Heron Therapeutics Inc. (NASDAQ: HRTX) Gains 3.14% From The High-Point? Read More »
Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference 2022/05/26 20:05:00 PR Newswire
SAN DIEGO, May 26, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced that company management…
Shares Of Heron Therapeutics Inc. (NASDAQ: HRTX) Could Show A Loss Of -1042.86% 2022/05/11 13:30:00 Marketing Sentinel
In the last trading session, 6.1 million shares of the Heron Therapeutics Inc. (NASDAQ:HRTX) were traded, and its beta was 1.37. Most recently the company’s share price was $3.50, and it changed around -$0.11 or -3.05% from the last close, which brings the market valuation of the company to $385.84M. HRTX currently trades at a … Shares Of Heron Therapeutics Inc. (NASDAQ: HRTX) Could Show A Loss Of -1042.86% Read More »
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript 2022/05/09 23:56:05 Seeking Alpha
Heron Therapeutics, Inc. (NASDAQ:NASDAQ:HRTX) Q1 2022 Results Conference Call May 09, 2022 04:30 PM ET Company Participants David Szekeres - EVP and COO Barry Quart - Chairman and CEO John…
Heron Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation 2022/03/04 21:13:23 Seeking Alpha
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off. 2022/03/04 21:00:00 The Motley Fool
Here''s why our roundtable loves Legend Biotech, Heron Therapeutics, and Pieris Pharmaceuticals.
Heron Therapeutics: Changing Strategy After Disappointing Earnings 2022/03/03 01:46:00 Seeking Alpha
Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference | MarketScreener 2022/03/02 21:06:07 MarketScreener
SAN DIEGO, March 2, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to… | March 2, 2022
Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference 2022/03/02 21:05:00 PR Newswire
SAN DIEGO, March 2, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that…